Ann: Shareholder Update on Section 249D Notice & Company Position, page-66

Keen to hear more from the potentials over the next week or so. Ultimately, I’ll be easily pleased, as I’ve been holding and buying since 60c to see $1.50+ and all the way down to 3.75c. The science v the tape has always been compelling, however many CRs and major dilution, with too much “Disallowed” charm from RC about his connected appointments, leads me to describe the last 9 years as abysmal.

Re-listening to the latest presentation - all about “we’re preparing for scaling”. Yet Ric questioned, “how many sales staff?” and Tim jumps in with …6! What % do these 6 take of costs? And no renal or CHF on the agenda and very little buy-in, in real $$, from the current board's own pockets. Sorry, but from my 9-year perspective the bar is set too low. I fear an agenda of an imminent ribbon-tied TO, and want to see some real proactivity in seizing this real opportunity/ies. Looking forward to more info and making a choice.